Hyperhomocysteinemic thrombosis

Wilcken DE et al. (1983) Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine.

Bass HN et al. (1997) Spontaneous pneumothorax in association with pyridoxine-responsive homocystinuria.

Lubec B et al. (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria.

Mandel H et al. (1996) Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.

None (1996) Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid.

Di Minno G et al. (1993) Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.

Malinow MR et al. (1994) Role of plasma homocyst(e)ine in arterial occlusive diseases.

Kozich V et al. (1995) Hyperhomocysteinemia in premature arterial disease: examination of cystathionine beta-synthase alleles at the molecular level.

Reish O et al. (1995) Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency.

Mudd SH et al. (1995) Plasma homocyst(e)ine or homocysteine?

Kurczynski TW et al. (1980) Maternal homocystinuria: studies of an untreated mother and fetus.

Mudd SH et al. (1981) A study of cardiovascular risk in heterozygotes for homocystinuria.

Skovby F et al. (1982) Immunochemical studies on cultured fibroblasts from patients with homocystinuria due to cystathionine beta-synthase deficiency.

None (1998) Ocular complications and a new surgical approach to lens dislocation in homocystinuria due to cystathionine-beta-synthetase deficiency.

Munnich A et al. (1983) Diet-responsive proconvertin (factor VII) deficiency in homocystinuria.

None (1982) The nature of the ocular zonule.

Tada K et al. (1967) Homocystinuria: amino acid pattern of the liver.

Spaeth GL et al. (1967) Prevalence of homocystinuria among the mentally retarded: evaluation of a specific screening test.

None (1967) Dietary treatment of homocystinuria.

None (1969) Homocystinuria: vitamin B6 dependent or not?

Carson NA et al. (1969) Treatment of homocystinuria with pyridoxine. A preliminary study.

Kaeser AC et al. (1969) Psychiatric and biochemical aspects of a case of homocystinuria.

None (1968) Activation of Hageman factor by L-homocystine.

Wong PW et al. (1968) The biosynthesis of cystathionine in patients with homocystinuria.

Carey MC et al. (1968) Homocystinuria. I. A clinical and pathological study of nine subjects in six families.

Pullin CH et al. (2002) Vitamin C therapy ameliorates vascular endothelial dysfunction in treated patients with homocystinuria.

Jakubowski H et al. (2008) Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans.

Elsaid MF et al. () Are heterocygotes for classical homocystinuria at risk of vitamin B12 and folic acid deficiency?

Hubmacher D et al. (2005) Modification of the structure and function of fibrillin-1 by homocysteine suggests a potential pathogenetic mechanism in homocystinuria.

None (1959) Renal abnormalities in the Marfan syndrome.

SCHIMKE RN et al. (1965) HOMOCYSTINURIA. STUDIES OF 20 FAMILIES WITH 38 AFFECTED MEMBERS.

MUDD SH et al. (1964) HOMOCYSTINURIA: AN ENZYMATIC DEFECT.

CARSON NA et al. (1963) HOMOCYSTINURIA: A NEW INBORN ERROR OF METABOLISM ASSOCIATED WITH MENTAL DEFICIENCY.

CARSON NA et al. (1962) Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland.

GERRITSEN T et al. (1962) The identification of homocystine in the urine.

Levy HL et al. (2002) Reproductive fitness in maternal homocystinuria due to cystathionine beta-synthase deficiency.

Gaustadnes M et al. (2002) The molecular basis of cystathionine beta-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment.

Kim YJ et al. (1974) On the mechanism of pyridoxine responsive homocystinuria. II. Properties of normal and mutant cystathionine beta-synthase from cultured fibroblasts.

Yaghmai R et al. (2002) Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency.

Schnyder G et al. (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.

Yap S et al. (2001) The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine beta-synthase deficiency.

Werstuck GH et al. (2001) Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.

Guttormsen AB et al. (2001) Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype.

Peterschmitt MJ et al. (1999) Reduction of false negative results in screening of newborns for homocystinuria.

Chao CL et al. (1999) The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis.

Gallagher PM et al. (1998) Characterization of mutations in the cystathionine beta-synthase gene in Irish patients with homocystinuria.

Yap S et al. (1998) Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control.

Harrison DA et al. (1998) Management of ophthalmic complications of homocystinuria.

Nugent A et al. (1998) Long-term survival of homocystinuria: the first case.

Kluijtmans LA et al. (1999) The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.

Fowler B et al. (1978) Homocystinuria. Evidence for three distinct classes of cystathionine beta-synthase mutants in cultured fibroblasts.

Mudd SH et al. (1969) A derangement in B 12 metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria.

Testai FD et al. (2010) Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders.

Urreizti R et al. (2006) The p.T191M mutation of the CBS gene is highly prevalent among homocystinuric patients from Spain, Portugal and South America.

Lee SJ et al. (2005) Identification and functional analysis of cystathionine beta-synthase gene mutations in patients with homocystinuria.

Wang L et al. (2005) Expression of mutant human cystathionine beta-synthase rescues neonatal lethality but not homocystinuria in a mouse model.

Kruger WD et al. (2003) Cystathionine beta-synthase deficiency in Georgia (USA): correlation of clinical and biochemical phenotype with genotype.

Kelly PJ et al. (2003) Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency.

Maclean KN et al. (2002) High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations.

Janosík M et al. (2001) Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria.

Gaustadnes M et al. (2000) Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.

Uhlendorf BW et al. (1968) Cystathionine synthase in tissue culture derived from human skin: enzyme defect in homocystinuria.

Kraus JP et al. (1999) Cystathionine beta-synthase mutations in homocystinuria.

Gaustadnes M et al. (1999) Prevalence of congenital homocystinuria in Denmark.

Tsai MY et al. (1996) High prevalence of a mutation in the cystathionine beta-synthase gene.

Kruger WD et al. (1995) A yeast assay for functional detection of mutations in the human cystathionine beta-synthase gene.

None (1994) Komrower Lecture. Molecular basis of phenotype expression in homocystinuria.

Watanabe M et al. (1995) Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Sebastio G et al. (1995) The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations.

Gallagher PM et al. (1995) High frequency (71%) of cystathionine beta-synthase mutation G307S in Irish homocystinuria patients.

Hu FL et al. (1993) Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria.

Skovby F et al. (1984) Homocystinuria: biogenesis of cystathionine beta-synthase subunits in cultured fibroblasts and in an in vitro translation system programmed with fibroblast messenger RNA.

Kluijtmans LA et al. (1996) Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.

Wilcken DE et al. (1976) The pathogenesis of coronary artery disease. A possible role for methionine metabolism.

Carey MC et al. (1968) Homocystinuria. II. Subnormal serum folate levels, increased folate clearance and effects of folic acid therapy.

McCully KS et al. (1970) Production of arteriosclerosis by homocysteinemia.

Shih VE et al. (1970) Pyridoxine-unresponsive homocystinuria.

Mudd SH et al. (1970) Homocystinuria due to cystathionine synthase deficiency: the effect of pyridoxine.

Shelley WB et al. (1972) Pyridoxine-dependent hair pigmentation in association with homocystinuria. The induction of melanotrichia.

Goldstein JL et al. (1973) Homocystinuria: heterozygote detection using phytohemagglutinin-stimulated lymphocytes.

Harker LA et al. (1974) Homocystinemia. Vascular injury and arterial thrombosis.

Shipman RT et al. (1969) Homocystinuria, addisonian pernicious anaemia, and partial deletion of a G chromosome.

Perry TL et al. (1968) Treatment of homocystinuria with a low-methionine diet, supplemental cystine, and a methyl donor.

None (1985) Vascular disease and homocysteine metabolism.

Boers GH et al. (1985) Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.

Boers GH et al. (1985) Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.

Wilcken DE et al. (1985) Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.

Mudd SH et al. (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

None (1985) Homocystinuria. Clinical, biochemical and genetic aspects of cystathionine beta-synthase and its deficiency in man.

Kang SS et al. (1986) Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.

Abbott MH et al. (1987) Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness.

Malinow MR et al. (1989) Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.

Burke JP et al. (1989) Ocular complications in homocystinuria--early and late treated.

Cochran FB et al. (1990) Pyridoxine-unresponsive homocystinuria with an unusual clinical course.

Collins JE et al. (1990) Pancreatitis and homocystinuria.

Uhlemann ER et al. (1976) Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency.

Almgren B et al. (1978) Abdominal aortic aneurysm in homocystinuria.

OMIM.ORG article